CardioComm Solutions, Inc.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Etienne Anthony Grima
- Full Time Employees
- 16
- Sector
- Technology services
- Industry
- Packaged software
- Address
- 18 Wynford Drive Toronto ON Canada M3C 3S2
- IPO Date
- Jul 6, 1995
- Website
- cardiocommsolutions.com
- Similar Companies
- Business
- CardioComm Solutions, Inc. develops and sells electrocardiogram and ambulatory arrhythmia monitoring solutions for medical and consumer markets, with operations focused on remote patient monitoring, telemedicine and cardiac data management. Founded in 1989 and headquartered in North York, Ontario, Canada, the company offers proprietary software, hardware and services including GEMS™ Global ECG Management System software; GEMS™ mobile and Home platforms; GlobalCardio™ EMR software; HealthCheck™ personal ECG monitors; HeartCheck™ handheld ECG devices and related mobile applications; ambulatory long-term continuous monitoring and 14-day Holter solutions; ECG reading, analysis, reporting and dashboard services; core laboratory and SMART Monitoring services; and telephonic and wireless ECG event recording solutions. The company serves physicians, clinics, hospitals, clinical trial sponsors, commercial monitoring providers and consumers, and it markets its technologies in North America and through global distribution and commercialization partnerships. Recent strategic developments include a June 2026 collaboration and joint development and intellectual property agreement with Predictiv AI Inc. to pursue AI-enabled healthcare software, automated ECG and biosignal interpretation, predictive analytics and workflow optimization, as well as a May 2026 decision to adopt the Coordinated Blanket Order 51-933 pilot and move from quarterly to semi-annual reporting. The company also announced an insider loan facility to support development of its GEMS Flex and 14-day Holter/LTCM platform and completed a royalty agreement termination in connection with that financing, underscoring its recent operational and product expansion efforts.
Company News
CardioComm Solutions and CancerCare Manitoba Launch Remote QT/QTc Interval Monitoring Pilot for Breast Cancer Patients
CardioComm Solutions and Predictiv AI Enter into Strategic AI Collaboration
CardioComm Announces Adoption of Quarterly Reporting Exemption Under Coordinated Blanket Order 51-933
CardioComm Receives TSX Venture Exchange Approval for Announced Loan Facility
CardioComm Terminates Royalty Agreement and Enters into $512,000 Insider Loan Facility to Advance Gems Flex and 14-Day Holter/LTCM Platform
CardioComm Solutions Announces Royalty-Based Financing Deal
CardioComm Solutions Inc. Announces Insider Purchase of Third-party Loan
CardioComm Solutions Closes Shares for Debt Transactions
CardioComm Solutions Announces Intention to Settle Outstanding Debt with Issuance of Shares
CardioComm Solutions Provides AGM Update Regarding Canada Post Strike
CardioComm Solutions Integrates ECG Technology into Sony's mSafety Platform
CardioComm Solutions Awarded Canadian Space Agency Contract for Design of Next Generation Connected Care Medical Module Prototype
CardioComm Solutions Secures Health Canada Clearance for Artificial Intelligence ECG Interpretation for Multiple Cardiac Arrhythmias
CardioComm Solutions, Inc. Secures Exclusive Distribution Rights in Quebec for ECG Medical Devices
CardioComm Solutions Enters Loan Agreement
Early Warning Press Release Regarding CardioComm Solutions, Inc.
CardioComm Solutions Completes Debt Settlement
CardioComm Solutions Provides Update Respecting Debt Settlement
CardioComm Solutions to Settle Outstanding Debt with Shares
CardioComm Solutions Appoints New Board Member and Provides Corporate Update